Structural and biophysical characterization of the 40 kDa PEG-interferon-α2a and its individual positional isomers

Bioconjugate Chemistry

Volumn 16, Issue 3, 2005, Pages 504-517

  Dhalluin, Christophe ^a   Ross, Alfred ^a   Leuthold, Luc Alexis ^a   Foser, Stefan ^a   Gsell, Bernard ^a   Müller, Francis ^a   Senn, Hans ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CIRCULAR DICHROISM SPECTROSCOPY; CONJUGATED POLYMERS; DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE SPECTROSCOPY; GLYCOPROTEINS; HYDRODYNAMICS; ISOMERS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEINS;

BIOPHYSICAL CHARACTERIZATION; CANCER DISEASE; COVALENT BINDING; HEPATITIS B; PEGYLATED; PHARMACOLOGICAL PROPERTIES; POSITIONAL ISOMERS; POTENT DRUGS; STRUCTURAL CHARACTERIZATION; VIRAL DISEASE;

AMINO ACIDS;

ALPHA2A INTERFERON; MACROGOL; POLYMER;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE SPECTROSCOPY; HYDRODYNAMICS; ISOMER; NUCLEAR MAGNETIC RESONANCE; ULTRACENTRIFUGATION;

EID: 18844427853     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc049781+     Document Type: Article

References (85)

1. Abuchowski, A., Van Es, T., Palczuk, N., and Davis, F. (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of poly-ethylene-glycol. J. Biol. Chem. 252, 3578-3581.
2. Bailon, P., and Berthold, W. (1998) Poly(ethylene glycol)-conjugated pharmaceuticals proteins. Pharm. Sci. Technol. Today 1, 352-356.
3. Wang, Y. S., Youngster, S., Bausch, J., Zhang, R., McNemar, C., and Wyss, D. F. (2000) Identification of the major positional isomer of pegylated Interferon alpha-2b. Biochemistry 39, 10634-10640.
4. Harris, J. M., and Chess, R. B. (2003) Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discovery 2, 214-221.
5. Fuerteges, F., and Abuchowski, A. (1990) The clinical efficacy of poly-(ethylene-glycol)-modified proteins. J. Controlled Release 11, 139-148.
6. Inada, I., Matsushima, A., Kodera, Y., and Nishimura, H. (1990) Polyethylene-Glycol (PEG)-proteins conjugates: applications to biomedical and biotechnological processes. J. Bioact. Compat. Polym. 5, 343-364.
7. Katre, N. V., Knauf, M. J., and Laird, W. (1987) Chemical modification of Interleukin-2 by polyethylene glycol increases its potency in the murine Meth A Sarcoma model. Proc. Natl. Acad. Sci. U.S.A. 84, 1487-1491.
8. Lisi, P. L., Van Es, T., Palczuk, N. C., and Davis, F. F. (1982) Enzyme therapy: Polyethylene-Glycol, α-glucuronidase conjugates as potential therapeutic agents in acid mucopolysacchararidosis. J. Appl. Biochem. 4, 19-33.
9. Veronese, F. M., Caliceti, P., and Schiavon, O. (1997) Branched and linear poly(ethylene glycol): influence of the polymer structure on enzymological, pharmacokinetic, and immunological properties of proteins conjugates. J. Bioact. Comput. Polym. 12, 196-207.
10. Knauf, M. J., Bell, D. P., Hirtzer, P., Luo, Z. P., Young, J. D., and Katre N. V. (1988) Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. J. Biol. Chem. 263, 15064-15070.
11. Yamaoka, T., Tabata, Y., and Ikada, Y. (1994) Distribution and tissue uptake of poly(ethylene-glycol) with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 4, 601-606.
12. Abuchowski, A., McCoy, J., Palczuk, N., Van Es, T., and Davis, F. (1977) Effect of covalent attachment of poly-ethylene-glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 252, 3582-3586.
13. Katre, N. V. (1990) Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. J. Immunol. 144, 209-213.
14. Heathcote, E. J., Shiftman, M. L., Cooksley, W. G., Dusheiko, G. M., Lee, S. S., Luis Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., Hoffman, J., and De Pamphilis, J. (2000) Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis. N. Engl. J. Med. 343, 1673-1680.
15. Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., Hoffman, J., and Brunda, M. J. (2000) Peginterferon Alfa-2a in Patients with Chronic Hepatitis C. N. Engl. J. Med. 343, 1666-1672.
16. Cohen, J. (1999) The Scientific Challenge of Hepatitis, C. Science. 285, 26-30.
17. Liang, T. J., Rehermann, B., Seeff, L. B., and Hoofnagle, J. H. (2000) Pathogenesis, natural history, treatment, and prevention of Hepatitis C. Ann. Intern Med. 132, 296-305.
18. Pol, S., Couzigou, P., Berliere, M., Abergel, A., Combis, J. M., Larrey, D., Tran, A., Moussali, J., Moussali, J., Poupon, R., Berthelot, P., and Brechot, C. (1999) A randomized trial of ribavirin and Interferon-α vs Interferon-α alone in patients with chronic Hepatitis C who were not responders to previous treatment. J. Hepatol. 31, 1-7.
19. Rostaing, L., Chatelut, E., Payen, J. L., Izopet, J., Thalamas, C., Ton-That, H., Pascal, J. P., Duramd, D., and Canal, P. (1998) Pharmacokinetics of alphaIFN-2b in chronic Hepatitis C virus patients undergoing hemodialysis or with normal renal function: clinical implications. J. Am. Soc. Nephrol. 9, 2344-2348.
20. Zeuzem, S. (1999) Clinical implications of Hepatitis C viral kinetics. J. Hepatol. 31, Sup. 1, 61-64.
21. Barouki, F. M., Witter, F. R., Griffin, D. E., Nadler, P. I., Woods, A., Wood, D. E., and Lietman, P. S. (1987) Time course for virus for 24 weeks following the completion of treatment of interferon levels, antiviral state, 2′,5′-oligoadenylate synthetase and side effects in healthy men. J. Interferon Res. 7, 29-39.
22. Wills, R. J. (1990) Clinical pharmacokinetics of Interferons. Clin. Pharmacokinet. 19, 390-399.
23. Monkarsh, S. P., Ma, Y., Aglione, A., Bailon, P., Ciolek, D., DeBarbieri, B., Graves, M. C., Hollfelder, K., Michel, H., Palleroni, A., Porter, J. E., Russoman, E., Roy, S., and Pan, Y. C. (1997) Positional isomers of monopegylated Interferonα-2a: isolation, characterization, and biological activity. Anal. Biochem. 247, 434-440.
24. Bailon, P., Palleroni, A., Schaffer, C., Spence, C., Fung, W., Porter, J., Ehrlich, G., Pan, W., Xu, Z. X., Modi, M., Farid, A., and Berthold, W. (2001) Rational design of a potent, long lasting form of Interferon: a 40 kDa branched Polyethylene Glycol-conjugated Interferonα-2a for the treatment of Hepatitis C. Bioconjugate Chem. 12, 195-202.
25. Fung, W. J., Porter, J. E., and Bailon, P. (1997) Strategies for the preparation and characterization of poly-(ethylene glycol) (PEG) conjugated pharmaceutical proteins. Polym. Prepr. 38, 565-566.
26. Caliceti, P., Schiavon, O., and Veronese, F. M. (1999) Biopharmaceutical properties of urecase conjugated to neutral and amphiphilic polymers. Bioconjugate Chem. 10, 638-646.
27. Wang, Y. S., Youngster, S., Grace, M., Bausch, J., Bordens, R., Wyss, D. F. (2002) Structural and biological characterization of pegylated recombinant interferon alpha-2b and ist therapeutic implications. Adv. Drug Delivery Rev. 54, 547-570.
28. Foser, S., Schacher, A., Weyer, K. A., Brugger, D., Dietel, E., Marti, S., and Schreitmüller, T. (2003) Isolation, structural characterization, and antiviral activity of positional Isomers of monopegylated Interferon alpha-2a. J. Prot. Exp. Purif. 30, 78-87.
29. Perry, M. C., and Jarvis, B. (2001) Peginterferon-α-2a (40 kD): a review of its use in the management of chronic Hepatitis C. Drugs 15, 2263-2288.
30. Lamb, M. V., and Martin, E. N. (2002) Weight-based versus fixed dosing of Peginterferon-α-2a (40 kDa). Ann. Pharmacother. 36, 933-938.
31. Roseng, L., Tolleshaug, H., and Berg, T. (1992) Uptake, intracellular transport, and degradation of polyethylene-glycol-modified Asialofetuin in hepatocytes. J. Biol. Chem. 267, 22987-22993.
32. So, T., Ueda, T., Yoshito, A., Nakamata, T., and Imoto, T. (1996) Situation of monomethoxypolyethylene glycol covalently attached to lyzozyme. J. Biochem. 119, 1086-1093.
33. Pradhananga, S., Wilkinson, I., and Ross, R. J. M. (2002) Receptor antagonists, Pegvisomant: structure and function. J. Mol. Endocrinol. 29, 11-14.
34. Youngster, S., Wang, Y. S., Grace, M., Bausch, J., Bordens, R., and Wyss, D. F. (2002) Structure, biology, and therapeutic implications of pegylated interferon alpha-2b. Curr. Pharm. Des. 8, 2139-2157.
35. Piehler, J., Roisman, L. C., and Schreiber, G. (2000) New structural and functional aspects of the type-I Interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem. 275, 40425-40433.
36. α2a (PEGASYS) and its individual positional isomers to the extracellular domain of the receptor IFNAR2. Bioconjugate Chem. 16, 518-527.
37. Hochuli, E. (1986) Large-scale recovery of Interferonα-2a synthesized in bacteria. Chimia 40, 408-412.
38. Baron, S., Tyring, S. K., Fleischmann, W. R., Coppenhaver, D. H., Niesel, D. W., Klimpel, G. R., Stanton, J., and Hughes, T. K. (1991) The interferons, mechanisms of action and clinical applications. JAMA 266, 1375-1383.
39. Kozlowski, A., and Harris, J. M. (2001) Improvements in protein PEGylation: pegylated interferons for treatment of Hepatitis C. J. Controlled Release 72, 217-224.
40. Klaus, W., Gsell, B., Labhardt, A., Wipf, B., and Senn, H. (1997) The three-dimensional high-resolution structure of human Interferonα-2a determined by heteronuclear NMR spectroscopy in solution. J. Mol. Biol. 374, 661-675.
41. Edsall, J. T. (1943) Protein, amino acids and peptides as ions and dipolar ions (Cohn, E. J., and Edsall, J. T., Eds.) pp 370-381, Reinhold, New York.
42. Schuck, P. (1994) Simultaneous radial and wavelength analysis with the Optima XL-A analytical ultracentrifuge. Prog. Colloid Polym. Sci. 94, 1-13.
43. Laue, T. M., and Stafford, W. F., III (1999) Modern Applications of Analytical Ultracentrifugation. Annu. Rev. Biophys. Biomol. Struct. 28, 75-100.
44. Lebowitz, J., Lewis, M. S., and Schuck, P. (2002) Modern analytical ultracentrifugation in protein science: A tutorial review. Prot. Sci., 11, 2067-2079.
45. George, A., Chiang, Y., Guo, B., Arabshahi, A., Cai, Z., and Wilson, W. (1997) Second virial coefficient as predictor in protein crystal growth. Methods Enzymol. 276, 100-110.
46. Berne, B. J., and Pecora, R. (1976) Dynamic Light Scattering, John Wiley and Sons, New York.
47. Provencher, S., and Glöckner, J. (1981) Estimation of globular protein secondary structure from circular dichroism. Biochemisty 20, 33-37.
48. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
49. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661-665.
50. 1H NMR spectroscopy of proteins. Biochem. Biophys. Res. Commun. 113, 854-860.
51. Braunschweiler, L., and Ernst, R. R. (1983) Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J. Magn. Reson. 53, 521-528.
52. Shaka, A. J., Barker, P. B., and Freeman, R. (1985) Computer-optimized decoupling scheme for wideband applications and low level operation. J. Magn. Reson. 64, 547-552.
53. Shaka, A. J., Lee, C. J., and Pines, A. (1988) Iterative schemes for bilinear operators; application to spin decoupling. J. Magn. Reson. 77, 274-293.
54. Sattler, M., Schleucher, J., and Griesinger, C. (1999) Heteronuclear multidimensional NMR experiments for the structure of proteins in solution employing pulsed field gradients. Prog. NMR Spectrosc. 34, 93-158.
55. Pervushin, K., Riek, R., Wider, G., and Wüthrich, K. (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. U.S.A. 94, 12366-12371.
56. Takahashi, H., Nakanishi, T., Kami, K., Arata, Y., and Shimada, I. (2000) A novel NMR method for determining the interfaces of large protein-protein complexes. Nat. Struct. Biol. 7, 220-223.
57. 15N Hartmann-Hahn multiple quantum coherence and Nuclear Overhauser multiple quantum coherence spectroscopy. Biochemistry 28, 6150-6156.
58. Gibbs, S. J., and Johnson, C. S. (1991) A PFG NMR experiment for accurate diffusion and flow studies in the presence of eddy currents. J. Magn. Reson. 93, 395-402.
59. Stejskal, E. O., and Tanner, J. E. (1965) Spin diffusion measurements: spin-echoes in the presence of a time dependent field gradient. J. Chem. Phys. 42, 288-292.
60. Weast, R. C. (1984) CRC Handbook of Chemistry and Physics, 64th ed., CRC Press, Boca Raton, FL.
61. Wüthrich, K. (1986) NMR of proteins and nucleic acids, John Wiley and Sons, New York.
62. Kessler, H., and Molter, M. (1976) Conformation of protected amino acids. V. Application of lanthanide-shift reagents for conformatiopnal studies of tert-butoxycarbonyl α-amino acid esters: equilibrium changes and kinetics of the isomerization. J. Am. Chem. Soc. 98, 5969-5973.
63. Jaikaran, D. C. J., and Wooley, G. A. (1995) Characterization of thermal isomerization at the single molecule level. J. Phys. Chem. 99, 13352-13355.
64. Wooley, G. A., Jaikaran, D. C. J., Zhang, Z., and Peng, S. (1995) Design of regulated Ion channels using measurements of cis/trans isomerization in single molecules. J. Am. Chem. Soc. 117, 4448-4454.
65. Kumar, A., Ernst, R. R., and Wüthrich, K. (1980) Two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95, 1-6.
66. Bothner-By, A. A., Stephens, R. L., Lee, J. M., Warren, C. D., and Jeanloz, R. W. (1984) Structure determination of a tetrasaccharide: transient Nuclear Overhauser effects in the rotating frame. J. Am. Chem. Soc. 106, 811-813.
67. Lepori, L., and Mollica, V. (1978) Volumetric properties of dilute aqueous solutions of poly(ethylene glycols). J. Polym. Sci., Polym. Phys. Ed. 16, 1123-1134.
68. Devanand, K., and Selser, J. C. (1991) Asymptotic behavior and long-range interactions in aqueous solutions of Poly-(ethylene oxide). Macromolecules 24, 5943-5947.
69. Kawaguchi, S., Imai, G., Suzuki, J., Miyahara, A., Kitano, T., and Ito, K. (1997) Aqueous solution properties of oligo-and poly(ethylene oxide) by static light scattering and intrinsic viscosity. Polymer 38, 2885-2891.
70. Chew, B., and Couper, A. (1973) Diffusion, viscosity and sedimentation of poly(ethylene oxide) in water. J. Chem. Soc., Faraday Trans. 1 72, 382-386.
71. Brown, W., Stilbs, P., and Johnsen, R. M. (1983) Friction coefficients in self-diffusion, velocity sedimentation, and mutual diffusion for poly(ethylene oxide) in aqueous solution. J. Polym. Sci. Polym. Phys. Ed. 21, 1029-1039.
72. Tanford, C. (1961) Physical Chemistry of Macromolecules, John Wiley and Sons, New York.
73. Wilkins, D. K., Grimshaw, S. B., Receveur, V., Dobson, C., Jones, J. A., and Smith, L. J. (1999) Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques. Biochemistry 38, 16424-16431.
74. Waggoner R. A., Blum, F. D., and Lang, J. C. (1995) Diffusion in aqueous solutions of Poly(ethylene glycol) at low concentrations. Macromolecules 28, 2658-2664.
75. Flory, P. J. (1969) Statistical mechanics of chain molecules, Wiley-Interscience, New York.
76. Maxfield, J., and Shepherd, T. J. (1975) Conformation of polyethylene-glycol oxide in the solid-state, melt, and solution measured raman scattering. Polymer 16, 505-512.
77. f-x Miktoarm star copolymers. Macromolecules 28, 1500-1505.
78. Aerts, J. (1998) Prediction of intrinsic viscosities of dendritic, hyperbranched and branched polymers. Comput. Theor. Polym. Sci. 8, 49-54.
79. Mazur, J., Guttman, C. M., and McCrackin, F. L. (1973) Monte Carlo studies of self-interacting polymer chains with excluded volume II Shape of a chain. Macromolecules 6, 872-874.
80. Rudnick, J., and Gaspari, G. (1987) The shapes of random walk. Science 237, 384-389.
81. Harris, J. M., Martin, N. E., and Modi, M. (2001) Pegylation, a novel process for modifying pharmacokinetics. Clin. Pharmacokinet. 40, 539-551.
82. Karnam, U. S., and Reddy, K. R. (2003) Pegylated Interferons. Clin. Liver Dis. 7, 139-148.
83. Algranati, N. E., Sy, S., and Modi, M. (1999) A branched methoxy 40 kDa polyethylene glycol (PEG) moiety optimizes the pharmacokinetics (PK) of peginterferon α-2a (PEG-IFN) and may explain its enhanced efficacy in chronic Hepatitis C (CHC). Hepatology 30, 4 Pt 2, 190A.
84. Müller, K., Ammann, H. J., Doran, D. M., Gerber, P. G., Gubernator, K., and Schrepfer, G., (1988) Complex heterocyclic structures: a challenge for computer assisted molecular modeling. Commun. Soc. Chim. Belg. 97, 655-667.
85. Gerber, P. G., and Müller (1995) MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. J. Comput.-Aided Mol. Des. 9, 251-268.